Get 20% lifetime commission for referring investors to digrin.com
here.
Zentalis Pharmaceuticals, Inc. ( ZNTL) - Stock Earnings
ZNTL Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 10, 2026, midnight | — / — | — | — / — | — |
ZNTL Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -35.2 million USD | — USD |
| 2026Q1 | -35.4 million USD | — USD |
| 2026Q2 | -77.6 million USD | — USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
ZNTL Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -292.2 million USD | — USD |
| 2024 | -165.8 million USD | 67.4 million USD |
| 2025 | -137.1 million USD | — USD |
| 2026 Est. | — | — |
ZNTL
Price: $2.13
52 week price:
Earnings Per Share: -1.94 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 349136
Market Capitalization: 190.8 million